Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Swedish Orphan Biovitrum International AB
AB
Active
Org 5563295624
Tomtebodavägen 23 A, 171 65
Solna
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1988
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Swedish Orphan Biovitrum International AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
10M
20M
29M
39M
34M
2020
23M
2021
24M
2022
23M
2023
24M
2024
EBITDA
SEK millions
0M
7M
13M
20M
26M
11M
2020
-52M
2021
1M
2022
22M
2023
23M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
33 961
23 458
23 921
23 253
24 166
Staff expenses
—
—
—
—
—
EBITDA
11 253
−51 850
1 290
21 929
23 164
Depreciation & amort.
—
—
—
—
−0
EBIT
11 253
−51 850
1 290
21 929
23 164
Net financials
−99 405
−97 250
−96 787
−87 055
501 598
Profit before tax
162 740
205 585
204 310
203 690
779 359
Tax
−49 695
−46 334
−46 475
−41 958
−40 042
Net profit
113 045
159 251
157 835
161 732
739 317
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 659 314
5 787 049
6 007 927
5 638 753
6 329 338
Equity
917 449
1 076 700
1 234 536
1 396 268
2 135 585
Long-term debt
4 688 794
4 694 112
4 758 493
4 139 248
4 186 244
Short-term debt
53 071
16 237
14 898
103 237
7 509
Total debt
4 741 865
4 710 349
4 773 391
4 242 485
4 193 753
Financial ratios
5-year trend
EBITDA margin
95.9%
This company
15.8%
Market median
+507% vs market
2020
2024
Equity ratio
33.7%
This company
38.2%
Market median
+12% vs market
2020
2024
Return on equity
34.6%
This company
18.4%
Market median
+88% vs market
2020
2024
Net profit margin
3059.3%
This company
8.1%
Market median
+37669% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.96×
This company
0.62×
Market median
-216% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Swedish Orphan Biovitrum International AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
